Episode: 89 - James E. Crowe, Jr. on AHEAD 100, a New Strategy for Preparing for the Next Pandemic

You can’t forecast the next epidemic with precision, so why do we keep building preparedness plans that depend on guessing? Host Dennis Burton, Ph.D., sits down with Jim Crowe, Jr., M.D., professor and director of the Vaccine Center at Vanderbilt University, to map a more durable approach: AHEAD 100—Advanced Human Epidemic Antibody Defenses 100—an index-fund-style program to create and stockpile human monoclonal antibody drugs for the 100 infections most likely to spark major outbreaks. The goal is to take best-in-class neutralizing antibodies, move them beyond early clinical testing, and get them ready to deploy when the world needs them. They also honestly discuss scientific accountability, what the public is asking of researchers, and how to think about gain-of-function research without slogans.

Links from this episode:
The Scripps Research Institute
Vanderbilt University Medical Center 

The Chain explores the lives, careers, research, and discoveries of protein engineers and scientists, the impact their work is having on the field, and where the industry is headed. Tune in to stay up to date on the newest advancements and to hear the stories that are impacting the world of biologics.